Helmut Albrecht is an Infectious Disease physician affiliated with Midlands Technical College. OpenAlex indexes 307 publications with 4,672 citations (h-index 37); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Richland Medical Park Dr Ste 420
Columbia, SC 292036833
Telephone
803-545-5350Registry record last updated 15 Mar 2018.
Clinical trials
- FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms
Sponsor: Fervent Pharmaceuticals
- Phase 4 Study - Mucinex D as Adjunct Therapy
Sponsor: Adams Respiratory Therapeutics
- Phase 2 Study - Erdosteine in Patients With CB/COPD
Sponsor: Adams Respiratory Therapeutics
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20256 payments
- ViiV Healthcare CompanyProgram year20252 payments
- Merck Sharp & Dohme LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
91.4%Protease Inhibitor27.6%Symtuza36%Evotaz33%Darunavir31%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor18.4%Descovy50%Triumeq50%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
8.6%Antidiarrheal8.6%Mytesi100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- CLINTRUSC Community Engagement & Outreach Core
University of South Carolina at Columbia
FY2026$284,564P20GM155896 - CLINTRUSC Community Engagement & Outreach Core
University of South Carolina at Columbia
FY2025$284,564P20GM155896 - CLINTRUSC Community Engagement & Outreach Core
University of South Carolina at Columbia
FY2024$296,814P20GM155896
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Multiplex quantitative detection of SARS-CoV-2 specific IgG and IgM antibodies based on DNA-assisted nanopore sensing
Biosensors and Bioelectronics
2021 - SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues
International Journal of Molecular Sciences
2021 - Cholesterol: A new game player accelerating vasculopathy caused by SARS-CoV-2?
American Journal of Physiology-Endocrinology and Metabolism
2020
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”